Advancing Neuroscience Through
Neurodiagnostics, Research, and Innovation
At Brazos Neuroscience, we are advancing neuroscience through neurodiagnostics, research, and innovation. Through our CLIA-certified and CAP-accredited laboratory, we provide objective biological data that supports informed decision-making for healthcare providers, attorneys, researchers, and patients. Guided by decades of scientific expertise, we help translate groundbreaking research into meaningful clinical insights.
Meet the Team Behind the Science
Our team brings together leaders in clinical practice, biomedical research, laboratory operations, and healthcare strategy to advance the future of neuroscience through precision testing, scientific collaboration, and commitment to scientific excellence.
Shea Spruill
President & Chief Executive Officer
Kevin P. Rosenblatt, M.D., Ph.D.
Chief Scientific Officer & Laboratory Director
Peter Bryant-Greenwood, M.D., MBA, FACHE, FCAP
Chief Medical Officer
Shea Spruill serves as President and Chief Executive Officer of Brazos Neuroscience and brings extensive experience in healthcare operations, laboratory development, and regulatory compliance.
Throughout his career, Shea has managed startup initiatives for de novo healthcare organizations, established laboratories, and hospital systems. He has overseen every stage of laboratory development—from planning and budgeting to build-out, staffing, regulatory readiness, and ongoing operations.
His experience spans multiple regulatory frameworks, including CLIA, COLA, CAP, and The Joint Commission. Having served in roles ranging from frontline laboratory positions to executive leadership, Shea understands the industry from both operational and strategic perspectives.
He earned his degree in Biology from Southwestern University in Georgetown, Texas, and holds his MT (AAB) certification.
Dr. Kevin Rosenblatt serves as Chief Scientific Officer and Laboratory Director at Brazos Neuroscience. He brings more than 40 years of clinical and biomedical research experience spanning academia, biotechnology, startups, and clinical practice.
A recognized leader in biomarker development, clinical genomics, and proteomics, Dr. Rosenblatt has authored more than 80 peer-reviewed publications and book chapters focused on cancer biology, neuronal biology, biomarker discovery, and translational medicine. He is a frequent lecturer at national and international scientific meetings.
After completing the combined M.D.–Ph.D. program at the University of Texas Southwestern Medical School, Dr. Rosenblatt completed his residency training in pathology and a research fellowship in cancer signaling and predictive biomarkers through the National Cancer Institute and the U.S. Food and Drug Administration.
Throughout his career, he has held numerous academic and leadership appointments, including Director of the Center for Clinical Proteomics at the Brown Foundation Institute of Molecular Medicine and Director of the Clinical and Translational Proteomics Service Center at UT Health Science Center. He also served as Associate Professor in the Division of Oncology at McGovern Medical School and as Adjunct Professor at MD Anderson Cancer Center.
His expertise continues to guide Brazos Neuroscience's commitment to scientific rigor, innovation, and excellence.
Dr. Peter Bryant-Greenwood serves as President and Chief Medical Officer of Brazos Neuroscience and brings more than 35 years of leadership experience in genomics, proteomics, personalized medicine, and laboratory diagnostics.
After earning his medical degree from the John A. Burns School of Medicine at the University of Hawaii, he completed residencies and fellowships at both the National Cancer Institute and the U.S. Food and Drug Administration. His career has included leadership positions directing molecular diagnostics, comprehensive genetics, and advanced laboratory services across major healthcare institutions.
Dr. Bryant-Greenwood previously served as Director of Molecular Diagnostics and Comprehensive Genetics at The Queen's Medical Center in Hawaii and later led molecular genomics initiatives at National Jewish Health, where he oversaw advanced diagnostic laboratories specializing in complex and esoteric testing.
As a Fellow of both the College of American Pathologists and the American College of Healthcare Executives, he brings a unique blend of scientific expertise, clinical leadership, and strategic vision to Brazos Neuroscience.
Shea Spruill
President & Chief Executive Officer
Shea Spruill serves as President and Chief Executive Officer of Brazos Neuroscience and brings extensive experience in healthcare operations, laboratory development, and regulatory compliance.
Throughout his career, Shea has managed startup initiatives for de novo healthcare organizations, established laboratories, and hospital systems. He has overseen every stage of laboratory development—from planning and budgeting to build-out, staffing, regulatory readiness, and ongoing operations.
His experience spans multiple regulatory frameworks, including CLIA, COLA, CAP, and The Joint Commission. Having served in roles ranging from frontline laboratory positions to executive leadership, Shea understands the industry from both operational and strategic perspectives.
He earned his degree in Biology from Southwestern University in Georgetown, Texas, and holds his MT (AAB) certification.
Kevin P. Rosenblatt, M.D., Ph.D.
Chief Scientific Officer & Laboratory Director
Dr. Kevin Rosenblatt serves as Chief Scientific Officer and Laboratory Director at Brazos Neuroscience. He brings more than 40 years of clinical and biomedical research experience spanning academia, biotechnology, startups, and clinical practice.
A recognized leader in biomarker development, clinical genomics, and proteomics, Dr. Rosenblatt has authored more than 80 peer-reviewed publications and book chapters focused on cancer biology, neuronal biology, biomarker discovery, and translational medicine. He is a frequent lecturer at national and international scientific meetings.
After completing the combined M.D.–Ph.D. program at the University of Texas Southwestern Medical School, Dr. Rosenblatt completed his residency training in pathology and a research fellowship in cancer signaling and predictive biomarkers through the National Cancer Institute and the U.S. Food and Drug Administration.
Throughout his career, he has held numerous academic and leadership appointments, including Director of the Center for Clinical Proteomics at the Brown Foundation Institute of Molecular Medicine and Director of the Clinical and Translational Proteomics Service Center at UT Health Science Center. He also served as Associate Professor in the Division of Oncology at McGovern Medical School and as Adjunct Professor at MD Anderson Cancer Center.
His expertise continues to guide Brazos Neuroscience's commitment to scientific rigor, innovation, and excellence.
Peter Bryant-Greenwood, M.D., MBA, FACHE, FCAP
Chief Medical Officer
Dr. Peter Bryant-Greenwood serves as President and Chief Medical Officer of Brazos Neuroscience and brings more than 35 years of leadership experience in genomics, proteomics, personalized medicine, and laboratory diagnostics.
After earning his medical degree from the John A. Burns School of Medicine at the University of Hawaii, he completed residencies and fellowships at both the National Cancer Institute and the U.S. Food and Drug Administration. His career has included leadership positions directing molecular diagnostics, comprehensive genetics, and advanced laboratory services across major healthcare institutions.
Dr. Bryant-Greenwood previously served as Director of Molecular Diagnostics and Comprehensive Genetics at The Queen's Medical Center in Hawaii and later led molecular genomics initiatives at National Jewish Health, where he oversaw advanced diagnostic laboratories specializing in complex and esoteric testing.
As a Fellow of both the College of American Pathologists and the American College of Healthcare Executives, he brings a unique blend of scientific expertise, clinical leadership, and strategic vision to Brazos Neuroscience.
Marc Mintz
Executive Vice President
Yeni Parga, MBA, MB
Laboratory Manager
Mark Ivezaj
National Sales Director
Marc Mintz is a seasoned business strategist with more than 30 years of international and domestic experience in strategic planning, marketing, capital raising, and business development.
He has successfully built and led international patient care initiatives, coordinating with hospitals throughout the United States while managing ongoing care for patients across the Middle East and North Africa. Most recently, Marc played a pivotal role in the growth strategy of VivoSense, helping secure early-stage investment and supporting business development initiatives.
Known for fostering collaboration and bringing people together around a common goal, Marc believes that with the right team and shared vision, extraordinary outcomes are possible.
Yeni Parga serves as Laboratory Manager at Brazos Neuroscience, where she oversees laboratory operations and supports the execution of efficient, high-quality testing workflows.
Prior to joining Brazos, Yeni held both technical and leadership positions across healthcare institutions, developing extensive expertise in molecular diagnostics, high-throughput laboratory workflows, and operational excellence. She earned her undergraduate degree in Molecular Technology from The University of Texas Health Science Center at Houston and MD Anderson Cancer Center School of Health Professions before obtaining her Master of Business Administration from the University of Houston–Downtown.
Her unique combination of scientific knowledge and business leadership helps ensure Brazos Neuroscience maintains its commitment to accuracy, efficiency, and exceptional service.
Mark Ivezaj is an accomplished healthcare executive with more than two decades of experience in healthcare operations, entrepreneurial leadership, and business development.
Holding a Master's degree in Healthcare Leadership, Mark has consistently driven organizational growth through strategic planning, operational excellence, and relationship development. Throughout his career, he has successfully launched and scaled specialized healthcare services while building high-performing teams dedicated to delivering exceptional results.
As National Sales Director, Mark leads initiatives to expand Brazos Neuroscience's market presence, cultivate strategic partnerships, and support providers nationwide through a commitment to service, innovation, and long-term collaboration.
Marc Mintz
Executive Vice President
Marc Mintz is a seasoned business strategist with more than 30 years of international and domestic experience in strategic planning, marketing, capital raising, and business development.
He has successfully built and led international patient care initiatives, coordinating with hospitals throughout the United States while managing ongoing care for patients across the Middle East and North Africa. Most recently, Marc played a pivotal role in the growth strategy of VivoSense, helping secure early-stage investment and supporting business development initiatives.
Known for fostering collaboration and bringing people together around a common goal, Marc believes that with the right team and shared vision, extraordinary outcomes are possible.
Yeni Parga, MBA, MB
Laboratory Manager
Yeni Parga serves as Laboratory Manager at Brazos Neuroscience, where she oversees laboratory operations and supports the execution of efficient, high-quality testing workflows.
Prior to joining Brazos, Yeni held both technical and leadership positions across healthcare institutions, developing extensive expertise in molecular diagnostics, high-throughput laboratory workflows, and operational excellence. She earned her undergraduate degree in Molecular Technology from The University of Texas Health Science Center at Houston and MD Anderson Cancer Center School of Health Professions before obtaining her Master of Business Administration from the University of Houston–Downtown.
Her unique combination of scientific knowledge and business leadership helps ensure Brazos Neuroscience maintains its commitment to accuracy, efficiency, and exceptional service.
Mark Ivezaj
National Sales Director
Mark Ivezaj is an accomplished healthcare executive with more than two decades of experience in healthcare operations, entrepreneurial leadership, and business development.
Holding a Master's degree in Healthcare Leadership, Mark has consistently driven organizational growth through strategic planning, operational excellence, and relationship development. Throughout his career, he has successfully launched and scaled specialized healthcare services while building high-performing teams dedicated to delivering exceptional results.
As National Sales Director, Mark leads initiatives to expand Brazos Neuroscience's market presence, cultivate strategic partnerships, and support providers nationwide through a commitment to service, innovation, and long-term collaboration.
